SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : KCAP - Key Capital Corporation
KCAP 1.960+2.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ACC who wrote (15)6/15/1998 5:28:00 PM
From: seminole  Read Replies (1) of 459
 
ACC

Something is not right here. Those Phase I references are very old.
Promising drugs go straight to Phase II without delay. Companies
with promising Phase I drugs don't need IPO's, they use licensing
agreements with large drug companies for territorial rights. The purpose of Phase I testing is to find toxicity. In phase I, the drug dose is increased until the toxic level is reached. I saw the web page, where they are leading investors to the offering, stating that no toxicity was found. Also the IPO maybe a new package on old data.

take care,
richard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News